Synonyms for pharmaceutical
ˌfɑr məˈsu tɪ kəlphar·ma·ceu·ti·cal

Princeton's WordNetRate these synonyms:1.0 / 1 vote

1. pharmaceutical, pharmaceuticadjective

   drug or medicine that is prepared or dispensed in pharmacies and used in medical treatment

   Synonyms:
   pharmaceutic

2. pharmaceutical, pharmaceuticadjective

   of or relating to pharmacy or pharmacists

   "the pharmaceutical industry"

   Synonyms:
   pharmaceutic

3. pharmaceuticaladjective

   of or relating to drugs used in medical treatment

   Synonyms:
   pharmaceutic

PPDB, the paraphrase databaseRate these paraphrases:0.0 / 0 votes

1. List of paraphrases for "pharmaceutical":

   pharmaceuticals, drug, pharmacy, farmaceutyczne, medicinal, pharmacists, pharmacist, pharma, medicines, drugs, medicine

How to pronounce pharmaceutical?

How to say pharmaceutical in sign language?

Words popularity by usage frequency

How to use pharmaceutical in a sentence?

1. Konstantinos Farsalinos:

   Unfortunately, the end result is that smokers are discouraged from using e-cigarettes as an alternative to smoking, for those smokers who cannot switch with, or do not want to use the pharmaceutical medications, e-cigarettes can really be life-saving.

2. Chief Executive Denise Scots-Knight:

   Our strategy is to build, over time, a diverse portfolio, and having publicly traded shares will provide additional flexibility to secure the next product candidates, which are likely to be primarily sourced from large pharmaceutical companies.

3. Wang Guiqiang:

   > SummaryCompaniesSome cities say peak of COVID infections was last monthToo early to say how many infections are severe-Chinese expertChina embassy in South Korea suspends short-term visasChinese state media criticise Pfizer over Paxlovid priceBEIJING, Jan 10( Reuters) - Many parts of China are already past their peak of COVID-19 infections, state media reported on Tuesday, with officials further downplaying the severity of the outbreak despite international concerns about its scale and impact.A summary by Health Times, a publication managed by Peoples Daily, Peoples Daily, said infections have been declining in the capital Beijing and several Chinese provinces. One official was quoted as saying nearly all the 100 million people in Henan province had already been infected.The virus has been spreading freely in China since a policy U-turn in early December after protests against a zero-COVID regime ruthlessly enforced for three years. China reopened its borders on Sunday, removing the last major restrictions.The frequent lockdowns, relentless testing and various levels of movement curbs since early 2020 have brought the worlds second-largest economy to one of its slowest growth rates in nearly half a century and caused widespread distress.With the virus let loose, China has stopped publishing daily infection tallies and has been reporting five or fewer deaths a day since the policy U-turn, figures that have been disputed by the World Health Organisation.Many Chinese funeral homes and hospitals say they are overwhelmed, and international health experts predict at least 1 million COVID-related deaths in China this year.On Tuesday, a Health Times compilation of reports from local government officials and health experts across the country, suggested the COVID wave may be past its peak in many regions.Kan Quan, director of the Office of the Henan Provincial Epidemic Prevention and Control, was cited as saying the infection rate in the central province was nearly 90 % as of Jan. 6. The number of patients at clinics in the province reached a peak on Dec. 19, but the number of severe cases was still high, he said, without giving further details.Yin Yong, acting mayor of Beijing, was cited as saying the capital was also past its peak. Li Pan, deputy director of the Municipal Health Commission in the city of Chongqing said the peak there was reached on Dec. 20. In the province of Jiangsu, the peak was reached on Dec. 22, while in Zheijiang province the first wave of infections has passed smoothly, officials said. Two cities in the southern Guangdong province, Chinas manufacturing heartland, reached their peaks before the end of the year.Separately in the state-run China Daily, a prominent health official said the percentage of severe cases remained unclear.It is still too early to conclude the overall percentage of severe and critical COVID patients in China as different types of hospitals report different numbers, Wang Guiqiang, head of Peking University First Hospitals infectious disease department, was quoted as saying.PFIZER CRITICISMChina has dismissed criticism over its data as politically-motivated attempts to smear its success in handling the pandemic and said any future mutations are likely to be more infectious but cause less severe illness.Testing requirements introduced by several countries, including the United States, Japan, South Korea, Britain, France and others in response to Chinas COVID outbreak, were called out by foreign ministry as discriminatory.Financial markets see the new curbs as mere inconvenience, with the yuan hitting a nearly five-month high on Tuesday.South Korean and Japanese shop owners, Thai tour bus operators and K-pop groups were among those licking their lips at the prospect of more Chinese tourists.Although Beijing also demands negative COVID test results from people landing in China, officials have threatened retaliation against countries mandating tests for visitors from China.The Chinese embassy in South Korea said on Tuesday it will stop issuing short-term visas for Korean citizens.State media has also taken a swipe at Pfizer Inc( PFE.N) over the price for its COVID treatment Paxlovid.It is not a secret that U.S. capital forces have already accumulated quite a fortune from the world via selling vaccines and drugs, and the U.S. government has been coordinating all along, nationalist tabloid Global Times said in an editorial.Pfizers Chief Executive Albert Bourla said on Monday the company was in discussions with Chinese authorities about a price for Paxlovid, but not over licensing a generic version in China.The abrupt change of course in COVID policies has left Chinas health system unprepared, with many hospitals ill-equipped to handle patients in critical conditions and smaller cities scrambling to secure basic anti-fever drug supplies.Yu Weishi, chairman of Youcare Pharmaceutical Group, told Reuters Li Pan firm boosted output of its anti-fever drugs five-fold to one million boxes a day in the past month.Wang Lili, general manager at another pharmaceutical firm, CR Double Crane, told Reuters that intravenous drips were their most in-demand product.The company has since Jan. 5 done away with weekends to meet demand.We are running 24/7.

4. Scott Gottlieb:

   It's important to underscore that, based on the FDA's initial evaluation, the increased risk of cancer to patients with NMBA exposure appears to be the same for NDMA exposure but less than the risk from NDEA exposure. That said, any presence of such impurities in drug products is not acceptable. Over the past few months, the FDA has conducted a major investigation and has worked with drug companies to address the presence of impurities in these products, our ongoing effort has determined that the impurities may be generated by specific chemical reactions in the manufacturing process of the drug's active pharmaceutical ingredients. FDA scientists have developed novel and sophisticated testing methods specifically designed to detect and measure N-Nitrosodimethylamine( NDMA) and N-Nitrosodiethylamine( NDEA) impurities in ARB medicines. Because of the potential for discovering other nitrosamine impurities, we are conducting an extensive organic chemistry analysis to develop novel testing methods to detect additional nitrosamine impurities, including NMBA.

5. Assistant Health Secretary Hugo López-Gatell:

   This proposal is being strongly pushed by the pharmaceutical companies, but it has been rejected by international organizations ... because there is no scientific evidence indicating the need for booster shots.